Nuclear Security Detectors
Radiation Monitoring & Isotope Identification
Pre-clinicalActive
Key Facts
About Actinia
Actinia is a private, pre-revenue biotechnology company commercializing novel halide perovskite semiconductor materials for radiation detection. Its flagship material, CsPbBr3 (CLB), has demonstrated record-breaking energy resolution for gamma-ray and X-ray detection, promising to double imaging resolution or halve patient dose in modalities like SPECT and CT. Spun out from Northwestern University with backing from Kairos Ventures, Actinia is positioned to disrupt the medical imaging and nuclear security markets with its foundational materials science IP.
View full company profile